GS
68
-4
VFC
53
-3
NWS
64
-2
CNX
80
4
KO
41
3
DVN
16
2
F
59
3
SWK
55
5
DUK
52
2
EW
37
5
DIS
82
-3
EMC
45
-3
MUR
42
2
PRU
62
2
ILMN
25
-7
CA
29
7
CI
45
2
ROK
60
-3
PPL
52
2
ALLE
30
-2
GS
68
-4
VFC
53
-3
NWS
64
-2
CNX
80
4
KO
41
3
DVN
16
2
F
59
3
SWK
55
5
DUK
52
2
EW
37
5
DIS
82
-3
EMC
45
-3
MUR
42
2
PRU
62
2
ILMN
25
-7
CA
29
7
CI
45
2
ROK
60
-3
PPL
52
2
ALLE
30
-2
Financhill
Back

Adaptive Biotechnologies Vs. Theriva Biologics Industry Stock Comparison

Sell
38

ADPT
Adaptive Biotechnologies

Last Price:
4.67
Seasonality Move:
-1.77%
Sell
39

TOVX
Theriva Biologics

Last Price:
1.26
Seasonality Move:
98.81%
Sell
38
Adaptive Biotechnologies (ADPT) is a Sell

Is Adaptive Biotechnologies a Buy, Sell or Hold?

  • The current Adaptive Biotechnologies [ADPT] share price is $4.68. The Score for ADPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ADPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $1.24. The Score for TOVX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADPT Stock Price Chart

What is Adaptive Biotechnologies's stock price today?

  • The Adaptive Biotechnologies share price today is $4.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $1.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.

ADPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 41.81 Sell
Chaikin Money Flow: -1263705 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.6 - 5.68) Sell
Bollinger Bands (100): (4.03 - 5.19) Buy

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 34.86 Sell
Chaikin Money Flow: -180611 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.34 - 1.86) Sell
Bollinger Bands (100): (1.78 - 5.78) Sell

ADPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.63 Sell
20-day SMA: 5.23 Sell
50-day SMA: 4.95 Sell
200-day SMA: 3.98 Buy
8-day EMA: 5.38 Sell
20-day EMA: 5.31 Sell
50-day EMA: 5.01 Sell
200-day EMA: 4.56 Buy

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.6 Sell
20-day SMA: 1.63 Sell
50-day SMA: 2.14 Sell
200-day SMA: 6.94 Sell
8-day EMA: 1.5 Sell
20-day EMA: 1.65 Sell
50-day EMA: 2.28 Sell
200-day EMA: 6.35 Sell

Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.26 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

Adaptive Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):